Ken Gall

Ken Gall is a seasoned professional with extensive experience in academia and the medical technology industry. Currently serving as Chief Commercial Officer, Co-Founder, and a member of the Board of Directors at restor3d since July 2017, Ken also holds the position of Professor at Duke University since July 2015. Ken's entrepreneurial ventures include co-founding multiple companies such as Reselute, Huxley Medical, Penderia, and Lacuna Medical, all while actively participating on various boards including PROTECT3D, Synergy Biomedical, Sparta Biomedical, and Orthobond Corporation. An alumnus of the University of Illinois Urbana-Champaign, Ken earned a PhD, a Master of Science, and a Bachelor of Science in Mechanical Engineering between 1992 and 1998.